Telen, Rey B.
HRN: 21-53-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/11/2022
07/18/2022
IV
500mg
Q8hrs
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice Follow NAG Recommended Antibiotic
Final appropriateness: Yes
Overall appropriateness: Yes